SNY

Sanofi ADR

Sep 16 • 01:33PM ET

47.05

+0.43 0.92 %

Healthcare • Drug Manufacturers - General • France • NASD

Peers: NVS PFE MRK GSK BMY LLY AZN JNJ ABBV AMGN

| Held by: PVAL FVD PPH PID AVDE BASV APIE QQQJ BUSA FENI

Index	-	P/E	11.75	EPS (ttm)	4.01	Insider Own	0.00%	Shs Outstand	2.61B	Perf Week	-0.84%
Market Cap	114.50B	Forward P/E	9.44	EPS next Y	4.98	Insider Trans	-	Shs Float	2.43B	Perf Month	-5.47%
Enterprise Value	122.95B	PEG	0.91	EPS next Q	1.65	Inst Own	10.26%	Short Float	0.21%	Perf Quarter	-4.78%
Income	9.94B	P/S	2.65	EPS this Y	22.16%	Inst Trans	-0.53%	Short Ratio	2.01	Perf Half Y	-20.15%
Sales	43.23B	P/B	1.39	EPS next Y	9.88%	ROA	4.70%	Short Interest	5.03M	Perf YTD	-2.45%
Book/sh	33.76	P/C	6.35	EPS next 5Y	12.90%	ROE	8.39%	52W High	60.12 -21.73%	Perf Year	-17.09%
Cash/sh	7.41	P/FCF	10.62	EPS past 3/5Y	-6.46% 13.05%	ROIC	9.99%	52W Low	44.73 5.19%	Perf 3Y	15.32%
Dividend Est.	2.39 (5.08%)	EV/EBITDA	8.16	Sales past 3/5Y	-0.15% 1.91%	Gross Margin	65.42%	Volatility	1.16% 1.38%	Perf 5Y	-8.38%
Dividend TTM	2.21 (4.70%)	EV/Sales	2.84	EPS Y/Y TTM	120.62%	Oper. Margin	24.88%	ATR (14)	0.95	Perf 10Y	-5.42%
Dividend Ex-Date	May 09, 2025	Quick Ratio	0.94	Sales Y/Y TTM	-9.32%	Profit Margin	22.98%	RSI (14)	43.46	Recom	1.76
Dividend Gr. 3/5Y	8.29% 6.46%	Current Ratio	1.27	EPS Q/Q	-	SMA20	-3.36%	Beta	0.50	Target Price	64.21
Payout	66.53%	Debt/Eq	0.32	Sales Q/Q	-	SMA50	-3.11%	Rel Volume	0.61	Prev Close	46.62
Employees	84587	LT Debt/Eq	0.21	Earnings	Jul 31 BMO	SMA200	-7.66%	Avg Volume	2.50M	Price	47.05
IPO	Jul 01, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.11% 3.35%	Trades		Volume	979,168	Change	0.92%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-08-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$58
Sep-02-25	Upgrade	Deutsche Bank	Hold → Buy
Aug-08-25	Upgrade	JP Morgan	Neutral → Overweight
Apr-15-25	Initiated	Exane BNP Paribas	Outperform	$65
Mar-21-25	Initiated	Goldman	Neutral	$65
Jan-30-25	Upgrade	Deutsche Bank	Sell → Hold
Jul-26-24	Reiterated	Argus	Buy	$55 → $60
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$55
Jan-16-24	Resumed	UBS	Buy
Dec-05-23	Downgrade	JP Morgan	Overweight → Neutral
Oct-30-23	Downgrade	Stifel	Buy → Hold
Sep-06-23	Upgrade	Berenberg	Hold → Buy
Jul-14-23	Initiated	HSBC Securities	Buy
Apr-28-23	Downgrade	Deutsche Bank	Hold → Sell
Mar-27-23	Upgrade	Barclays	Equal Weight → Overweight
Dec-13-22	Resumed	Morgan Stanley	Overweight
Aug-12-22	Upgrade	Deutsche Bank	Sell → Hold
Aug-09-22	Downgrade	UBS	Buy → Neutral
May-23-22	Initiated	SVB Leerink	Outperform
Sep-27-21	Upgrade	SVB Leerink	Mkt Perform → Outperform

Show Previous Ratings

Sep-15-25 09:53AM	REGN Loses 21.1% Year to Date: Buy, Sell or Hold the Sock? (Zacks)
08:15AM	Leerink Partners Maintains a Buy Rating on Sanofi (SNY) (Insider Monkey)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
12:11PM	Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. (Barrons.com)
Sep-11-25 12:45PM	SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag (Zacks)
09:48AM	Loading…
09:48AM	Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? (Zacks)
Sep-10-25 08:00AM	Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS (PR Newswire)
Sep-08-25 04:06PM	Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again (Investor's Business Daily)
11:27AM	NKTR Shares Surge 38.2% in a Week: Here's What You Should Know (Zacks)
Sep-05-25 02:51PM	Sanofi (SNY) Loses 9% as New Drug Candidate Appears Weaker Than Predecessor (Insider Monkey)
01:32PM	Why Nektar Therapeutics Rippled Higher This Week (Motley Fool)
Sep-04-25 04:14PM	Sanofi Tumbles As New Eczema Drug Lags Dupixent's 'Compelling Bar' (Investor's Business Daily) -9.14%
03:55PM	Sanofi Drops As Eczema Drug Faces Big Test (GuruFocus.com)
02:36PM	Why Is Sanofi Stock Falling Thursday? (Benzinga)
10:48AM	SNY Down Despite Eczema Candidate Meeting Goal in Phase III Study (Zacks)
10:30AM	Loading…
10:30AM	TEVA Stock Up More Than 19% in a Month: Buy, Sell or Hold the Stock? (Zacks)
09:21AM	Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors (Benzinga)
07:45AM	Stocks to Watch Thursday: Salesforce, Figma, GitLab, American Eagle (The Wall Street Journal)
05:21AM	Sanofi Shares Sink as Experimental Drug Results Disappoint (The Wall Street Journal)
01:46AM	Sanofis Eczema Drug Candidate Hits Main Goals in Late-Stage Trial (The Wall Street Journal)
Sep-03-25 10:07AM	MRK Posts Cholesterol Drug Data, Focus Shifts Back to Its Pipeline (Zacks)
Sep-01-25 12:30PM	Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia (Zacks)
Aug-31-25 01:57AM	Sanofi (SNY) Expands Pipeline Through Multi-Billion Acquisitions Despite Earnings Miss (Insider Monkey)
Aug-29-25 05:12AM	Sanofi (SNY)'s Sarclisa Gets EMA Nod for Multiple Myeloma (Insider Monkey)
Aug-28-25 09:21AM	Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line? (Zacks)
Aug-26-25 11:00AM	New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week (PR Newswire)
12:14AM	Sanofi (SNY) Receives Orphan Designation for Rilzabrutinib (Insider Monkey)
Aug-18-25 05:49AM	Sanofi receives orphan status from EMA for rilzabrutinib (Pharmaceutical Technology)
Aug-15-25 10:10AM	Can Eylea HD and Dupixent Profits Revive Regeneron Stock? (Zacks)
09:50AM	SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease (Zacks)
01:00AM	Loading…
Aug-14-25 01:00AM	Press Release: Sanofis rilzabrutinib earns orphan designation in the EU for IgG4-related disease (GlobeNewswire)
Aug-12-25 06:36AM	Sanofi halts Praluent supply in China due to limited availability (Investing.com)
Aug-07-25 11:14AM	NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View (Zacks)
Aug-06-25 02:19PM	Moderna's stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals (MarketWatch)
01:00AM	Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. (GlobeNewswire)
Aug-05-25 05:45PM	Analyst Report: Sanofi (Morningstar Research)
10:17AM	BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View (Zacks)
Aug-02-25 07:48AM	EU Approves Sanofi's (SNY) Sarclisa for Newly Diagnosed Multiple Myeloma Patients (Insider Monkey)
Aug-01-25 11:10AM	Regeneron Stock Rises on Q2 Earnings and Sales Beat, Eylea HD Sales Up (Zacks)
08:40AM	Regeneron Stock Is Rising on Earnings. This Sanofi Collaboration Is Helping. (Barrons.com)
08:15AM	Reddit, Coinbase, Novo Nordisk - Trending Stocks (Yahoo Finance Video)
05:43AM	Tariffs Weigh on Global Stocks; Amazon Slumps: Markets Wrap (Bloomberg)
Jul-31-25 04:16PM	What Trump's Big Pharma CEO letters mean for drug pricing power (Yahoo Finance Video) -7.33%
03:40PM	Analyst Report: Sanofi (Morningstar Research)
12:20PM	Press release: Online availability of Sanofis half-year financial report for 2025 (GlobeNewswire)
10:37AM	Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down (Zacks)
09:01AM	Sanofi CEO Paul Hudson on Q2 results, Dupixent demand and tariff impact (CNBC TV)
01:54AM	Sanofi Upbeat on Sales Outlook After Faster-Than-Expected Growth (The Wall Street Journal)
01:30AM	Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range (GlobeNewswire)
Jul-30-25 01:00AM	Press Release: Sanofis SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma (GlobeNewswire)
Jul-29-25 09:12AM	AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs Outperform (Zacks)
Jul-25-25 11:33AM	RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now? (Zacks)
01:00AM	Press Release: Sanofis Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma (GlobeNewswire)
Jul-24-25 01:28PM	Analyst Report: Sanofi (Morningstar Research)
Jul-22-25 02:09PM	Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy (Benzinga)
11:57AM	BEYFORTUS reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study (PR Newswire)
07:59AM	Sanofi to Buy Vaccine Developer Vicebio for Up to $1.6 Billion (The Wall Street Journal)
01:30AM	Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline (GlobeNewswire)
Jul-21-25 06:32PM	Sanofi (SNY) Expands Rare Disease Reach With $9.5B Blueprint Deal (Insider Monkey)
Jul-18-25 09:54AM	Kymera Surges 70% in 3 Months: Buy, Sell or Hold the Stock? (Zacks)
09:52AM	Regeneron Stock Plunges 22.6% YTD: Should You Buy, Sell or Hold? (Zacks)
01:00AM	Press Release: Sanofi completes acquisition of Blueprint Medicines (GlobeNewswire)
Jul-17-25 11:30AM	Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock (Zacks)
01:00AM	Press Release: Sanofi announces extension of Blueprint tender offer (GlobeNewswire)
Jul-16-25 11:54AM	Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag (Zacks)
01:00AM	Press Release: Sanofis SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration (GlobeNewswire)
Jul-14-25 10:23AM	MRK's Buyout Spree to Broaden Product Portfolio: Can it Aid Growth? (Zacks)
Jul-12-25 09:36AM	FDA willing to trade faster drug reviews for lower prices, Bloomberg reports (TipRanks)
Jul-11-25 08:31AM	TEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock? (Zacks)
Jul-09-25 12:29PM	Sanofi: Information concerning the total number of voting rights and shares - June 2025 (GlobeNewswire)
09:19AM	Verona Pharma Stock Jumps 20% on $10B Buyout Offer From Merck (Zacks)
09:19AM	GSK's Specialty Medicines Unit on a Strong Footing: Here's Why (Zacks)
Jul-08-25 03:31PM	Regenerons Blockbuster Dupixent Faces a New Rival (Barrons.com)
09:59AM	DNLI's BLA for Hunter Syndrome Drug Gets FDA's Priority Review (Zacks)
Jul-07-25 04:27PM	Apogee Dives. But It Could Eventually Rival Sanofi's Biggest Moneymaker. (Investor's Business Daily)
Jul-06-25 03:35AM	FDA Grants Orphan Drug Designation To Sanofi's (SNY) Riliprubart (Insider Monkey)
03:35AM	Sanofi's (NASDAQ:SNY) Riliprubart Granted Orphan Frug Designation in Japan (Insider Monkey)
Jul-04-25 09:00AM	How Much of Your Portfolio Should Be in International Stocks? (The Wall Street Journal)
Jul-03-25 07:08AM	Mercedes to LVMH Are Blunting the EUs Fight Against Trumps Tariffs (Bloomberg)
Jul-02-25 08:46AM	Will AbbVie's Acquisition Spree Aid Pipeline Growth? (Zacks)
Jul-01-25 12:55PM	10 European Dividend Stocks That Could Beat Their U.S. Counterparts (Barrons.com)
07:00AM	Adagene announces up to $25 million strategic investment from Sanofi (GlobeNewswire)
Jun-30-25 11:00AM	Hedge Fund Strategy Built on Catastrophes Taps Hot New Trend (Bloomberg)
01:30AM	Press release: Availability of the Q2 2025 Aide mémoire (GlobeNewswire)
01:00AM	Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy (GlobeNewswire)
Jun-27-25 10:19AM	Kymeras partnerships with Sanofi and Gilead drive value (Investing.com)
Jun-26-25 02:28PM	The Anti-Vax Movement Solidifies Control of the CDCs Vaccine Committee (Barrons.com)
10:45AM	Kymera weakness a buying opportunity, says Stifel (TipRanks)
09:06AM	Morning Movers: General Mills dips following fourth quarter report (TipRanks)
08:40AM	KYMR Collaborates With GILD; Stock Down on Sanofi Deal Update (Zacks)
08:00AM	Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts (PR Newswire)
Jun-25-25 10:02AM	Sanofi's Experimental Transplant Rejection Drug Gets FDA Orphan Tag (Zacks)
01:00AM	Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation (GlobeNewswire)
Jun-24-25 09:56AM	Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip? (Zacks)
Jun-23-25 12:34PM	SNY Gets CHMP Nod for Expanded Use of Sarclisa in Multiple Myeloma (Zacks)
01:00AM	Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-eligible newly diagnosed multiple myeloma (GlobeNewswire)
Jun-20-25 09:46AM	Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid (Zacks)
05:11AM	DoH Abu Dhabi and Sanofi link for vaccine development (Pharmaceutical Technology)
01:00AM	Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid (GlobeNewswire)
Jun-19-25 10:23AM	What is the Intent Behind Eli Lilly's Recent M&A Deals Spree? (Zacks)

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SNY

Sanofi ADR

Upgrade your FINVIZ experience